You have no items in your shopping cart.
RecombinantIL-2,Human [orb1494709]> 95% as analyzed by SDS-PAGE.
15~16 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg- RecombinantIL-1β,Human(CHO-expressed) [orb1494711]
> 95% as analyzed by SDS-PAGE and HPLC.
17kDa, observed by non-reducing SDS-PAGE.
CHO
10 μg, 50 μg, 1 mg - RecombinantIL-1α,Rat [orb1494712]
> 95% as analyzed by SDS-PAGE.
17~22 kDa, observed by reducing SDS-PAGE.
CHO
10 μg, 50 μg, 1 mg - RecombinantIL-12,Mouse [orb1494718]
> 95% as analyzed by SDS-PAGE.
27-29 kDa (p35) and 45-50 kDa (p40), observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg, 1 mg - RecombinantIL-12,His,Rat [orb1494719]
> 95% as analyzed by SDS-PAGE.
26-28kDa (p35) and 42-45 kDa (p40), observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg, 1 mg - RecombinantIL-10,Rat(CHO-expressed) [orb1494721]
> 95% as analyzed by SDS-PAGE and HPLC.
8-22 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg, 1 mg - RecombinantIL-10,Mouse(CHO-expressed) [orb1494722]
> 95% as analyzed by SDS-PAGE and HPLC.
21-23 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg, 1 mg - RecombinantIL-10,Human(CHO-expressed) [orb1494723]
> 95% as analyzed by SDS-PAGE and HPLC.
18-19 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg, 1 mg